HCL Technologies (HCL), and Oracle Health Sciences have tied up to help life sciences companies execute and scale the next generation of digital clinical trials to reduce the time and cost of drug development.

The collaboration includes the availability of HCL’s Faster Intelligent Trials (FIT) Solution using Oracle Health Sciences Mobile Health (mHealth) Connector Cloud Service (Oracle mHealth Cloud).

Shrikanth Shetty, Executive Vice President and North America Business Head for Life Sciences and Healthcare, HCL, said, “Although many of our customers have already established a strong case for leveraging mHealth technologies in clinical trials or digital therapies through proof of concept, we still see a chasm between the potential and actual adoption at scale.”

HCL’s FIT solution can be leveraged for cases like improving patient engagement, collecting patient reported outcomes, monitoring patient safety, improving medication adherence, or conducting e- visits during clinical trials to reduce patient and site burden.

The solution can also be applied for drugs already launched commercially, such as for remote patient monitoring, gathering real world evidence, or as an accompanying application for digital therapies.

Speaking on the tie-up, Jim Streeter, Global Vice President, Product Strategy, for Oracle Health Sciences, said the collaboration between Oracle Health Sciences and HCL enabled clinical teams to establish digitally enabled clinical trial processes and new digital trial methods such as remote patient monitoring.